Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.05
AMED's Cash to Debt is ranked higher than
54% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. AMED: 0.05 )
AMED' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.05

Equity to Asset 0.56
AMED's Equity to Asset is ranked higher than
82% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. AMED: 0.56 )
AMED' s 10-Year Equity to Asset Range
Min: -0.31   Max: 0.79
Current: 0.56

-0.31
0.79
F-Score: 3
Z-Score: 3.26
M-Score: -2.02
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -0.07
AMED's Operating margin (%) is ranked higher than
58% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 8.59 vs. AMED: -0.07 )
AMED' s 10-Year Operating margin (%) Range
Min: -76.87   Max: 15.25
Current: -0.07

-76.87
15.25
Net-margin (%) -0.50
AMED's Net-margin (%) is ranked higher than
61% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 4.91 vs. AMED: -0.50 )
AMED' s 10-Year Net-margin (%) Range
Min: -65.3   Max: 9.33
Current: -0.5

-65.3
9.33
ROE (%) -1.60
AMED's ROE (%) is ranked higher than
60% of the 286 Companies
in the Global Medical Care industry.

( Industry Median: 9.56 vs. AMED: -1.60 )
AMED' s 10-Year ROE (%) Range
Min: -54.77   Max: 775.52
Current: -1.6

-54.77
775.52
ROA (%) -0.83
AMED's ROA (%) is ranked higher than
60% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 3.52 vs. AMED: -0.83 )
AMED' s 10-Year ROA (%) Range
Min: -73.91   Max: 15.23
Current: -0.83

-73.91
15.23
ROC (Joel Greenblatt) (%) -0.55
AMED's ROC (Joel Greenblatt) (%) is ranked higher than
58% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 18.24 vs. AMED: -0.55 )
AMED' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -328.03   Max: 387.62
Current: -0.55

-328.03
387.62
Revenue Growth (%) -11.30
AMED's Revenue Growth (%) is ranked higher than
54% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 6.10 vs. AMED: -11.30 )
AMED' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 35.1
Current: -11.3

0
35.1
» AMED's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

AMED Guru Trades in Q4 2013

Charles Brandes 215,640 sh (-5.9%)
» More
Q1 2014

AMED Guru Trades in Q1 2014

Jim Simons 144,680 sh (New)
Charles Brandes 165,125 sh (-23.43%)
» More
Q2 2014

AMED Guru Trades in Q2 2014

Jim Simons 338,601 sh (+134.03%)
Charles Brandes 165,290 sh (+0.1%)
» More
Q3 2014

AMED Guru Trades in Q3 2014

Paul Tudor Jones 13,000 sh (New)
Steven Cohen 62,400 sh (New)
Jim Simons 259,501 sh (-23.36%)
Charles Brandes 15,810 sh (-90.43%)
» More
» Details

Insider Trades

Latest Guru Trades with AMED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Charles Brandes 2014-09-30 Reduce -90.43%0.03%$15.58 - $21.78 $ 25.7933%15810
Charles Brandes 2014-03-31 Reduce -23.43%0.01%$14.09 - $16.96 $ 25.7968%165125
Charles Brandes 2013-03-31 Add 515.74%0.03%$10.95 - $13.11 $ 25.79122%225885
Joel Greenblatt 2012-12-31 Sold Out 0.06%$9.65 - $13.56 $ 25.79128%0
Charles Brandes 2012-12-31 New Buy$9.65 - $13.56 $ 25.79128%36685
Joel Greenblatt 2012-09-30 Reduce -49.75%0.06%$11.3 - $15.84 $ 25.7989%65015
Charles Brandes 2012-09-30 Sold Out 0.0017%$11.3 - $15.84 $ 25.7989%0
John Hussman 2012-06-30 Sold Out 0.04%$9.87 - $15.03 $ 25.79108%0
Joel Greenblatt 2012-03-31 Add 98.71%0.09%$9.56 - $14.66 $ 25.79134%144813
Charles Brandes 2012-03-31 New Buy$9.56 - $14.66 $ 25.79134%20195
David Dreman 2011-12-31 Sold Out 0.5%$9.59 - $14.56 $ 25.79120%0
George Soros 2011-12-31 Sold Out 0.0041%$9.59 - $14.56 $ 25.79120%0
Charles Brandes 2011-12-31 Sold Out 0.0021%$9.59 - $14.56 $ 25.79120%0
Joel Greenblatt 2011-09-30 Add 125.99%0.09%$13.29 - $27.55 $ 25.7930%64379
George Soros 2011-09-30 Reduce -91.93%0.07%$13.29 - $27.55 $ 25.7930%16100
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.20
AMED's P/B is ranked higher than
79% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 2.96 vs. AMED: 2.20 )
AMED' s 10-Year P/B Range
Min: 0.5   Max: 6.34
Current: 2.2

0.5
6.34
P/S 0.70
AMED's P/S is ranked higher than
85% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. AMED: 0.70 )
AMED' s 10-Year P/S Range
Min: 0.18   Max: 2.36
Current: 0.7

0.18
2.36
EV-to-EBIT -1146.65
AMED's EV-to-EBIT is ranked higher than
56% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 22.71 vs. AMED: -1146.65 )
AMED' s 10-Year EV-to-EBIT Range
Min: -1133.1   Max: 18.9
Current: -1146.65

-1133.1
18.9
Current Ratio 0.75
AMED's Current Ratio is ranked higher than
57% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. AMED: 0.75 )
AMED' s 10-Year Current Ratio Range
Min: 0.25   Max: 2.88
Current: 0.75

0.25
2.88
Quick Ratio 0.75
AMED's Quick Ratio is ranked higher than
58% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 1.21 vs. AMED: 0.75 )
AMED' s 10-Year Quick Ratio Range
Min: 0.21   Max: 2.85
Current: 0.75

0.21
2.85

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 6.00
AMED's Price/Tangible Book is ranked higher than
76% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 33.51 vs. AMED: 6.00 )
AMED' s 10-Year Price/Tangible Book Range
Min: 0.79   Max: 122.85
Current: 6

0.79
122.85
Price/DCF (Projected) 0.80
AMED's Price/DCF (Projected) is ranked higher than
95% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 4.19 vs. AMED: 0.80 )
AMED' s 10-Year Price/DCF (Projected) Range
Min: 0.16   Max: 30
Current: 0.8

0.16
30
Price/Median PS Value 0.70
AMED's Price/Median PS Value is ranked higher than
95% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. AMED: 0.70 )
AMED' s 10-Year Price/Median PS Value Range
Min: 0.13   Max: 2.28
Current: 0.7

0.13
2.28
Price/Peter Lynch Fair Value 0.40
AMED's Price/Peter Lynch Fair Value is ranked higher than
63% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. AMED: 0.40 )
AMED' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.21   Max: 3.24
Current: 0.4

0.21
3.24
Earnings Yield (Greenblatt) -0.10
AMED's Earnings Yield (Greenblatt) is ranked higher than
58% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 4.80 vs. AMED: -0.10 )
AMED' s 10-Year Earnings Yield (Greenblatt) Range
Min: -0.1   Max: 33.7
Current: -0.1

-0.1
33.7
Forward Rate of Return (Yacktman) 40.55
AMED's Forward Rate of Return (Yacktman) is ranked higher than
85% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 9.05 vs. AMED: 40.55 )
AMED' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1.5   Max: 104.3
Current: 40.55

-1.5
104.3

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:ADY.Germany
Amedisys Inc was originally incorporated in Louisiana in 1982. Its operations were transferred to a Delaware corporation, which was incorporated in 1994; and became a publicly traded company in August of that year. The Company is a provider of low-cost home health services to the chronic, co-morbid, aging American population. The operations involve servicing patients through its two reportable business segments: home health and hospice. The home health segment delivers services in the homes of individuals who may be recovering from an illness, injury or surgery. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Individuals with a terminal illness such as heart disease, pulmonary disease, dementia, Alzheimers, HIV/AIDS or cancer may be eligible for hospice care. The Company operates 41 home health care centers and five hospice care centers with care centers servicing the same markets, sold 19 home health care centers and one hospice care center and closed 10 home health care centers. The Companys operations are regulated by Federal, state and local authorities.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK